Immunotherapy for Alzheimer's disease: will vaccination work?
- 1 March 2003
- journal article
- review article
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 9 (3) , 85-87
- https://doi.org/10.1016/s1471-4914(03)00022-4
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Amyloid-β immunotherapy for Alzheimer's disease: the end of the beginningNature Reviews Neuroscience, 2002
- Immunization reverses memory deficits without reducing brain Aβ burden in Alzheimer's disease modelNature Neuroscience, 2002
- Nerve inflammation halts trial for Alzheimer's drugNature, 2002
- Immunization with a Nontoxic/Nonfibrillar Amyloid-β Homologous Peptide Reduces Alzheimer's Disease-Associated Pathology in Transgenic MiceThe American Journal of Pathology, 2001
- Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's diseaseProceedings of the National Academy of Sciences, 2001
- Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's diseaseNature, 2000
- Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's diseaseNature, 2000
- Nasal administration of amyloid-? peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's diseaseAnnals of Neurology, 2000
- Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer diseaseNature Medicine, 2000
- Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouseNature, 1999